Maggie Flanagan LeFlore

Keine laufenden Positionen mehr

Consumer Services

Health Technology

Finance

Profil

Maggie Flanagan LeFlore worked as a Managing Director at MedImmune Ventures, Inc. from 2007 to 2010.
She also worked as a Director at Astria Therapeutics, Inc. and NKT Therapeutics, Inc. In terms of education, she earned a doctorate degree from Indiana University and an undergraduate degree from the University of Kansas.

Ehemalige bekannte Positionen von Maggie Flanagan LeFlore

Unternehmen	Position	Ende
MedImmune Ventures, Inc. MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland.	Private Equity Investor	30.03.2010
ASTRIA THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	-
NKT Therapeutics, Inc. NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA.	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Maggie Flanagan LeFlore im Detail an

Ausbildung von Maggie Flanagan LeFlore

University of Kansas	Undergraduate Degree
Indiana University	Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Maggie Flanagan LeFlore im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
ASTRIA THERAPEUTICS, INC.	Health Technology

Private Unternehmen	2
MedImmune Ventures, Inc. MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland.	Finance
NKT Therapeutics, Inc. NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA.	Health Technology

Sehen Sie sich die Unternehmensverbindungen an